Newsfile Corp
08 Oct 2026, 19:30 UTC · 1h ago
Kaplan Fox & Kilsheimer LLP Encourages Hims & Hers Health, Inc. (HIMS) Investors With Losses to Seek Appointment as Lead Plaintiff Before November 2, 2026
Impact · against what's priced in
The announcement of a securities class action lawsuit against Hims & Hers is a marginal negative that confirms the existing legal drag already factored into the stock price. The underlying regulatory issues involving the FTC and data sharing with Meta and Snap are already fully reflected in the current valuations of all three companies.
- HIMS−0.10
Already priced in
- The price assumes
Significant legal and regulatory friction, including FTC lawsuits over data privacy and billing practices.





